National Engineering Laboratory for Druggable Gene and Protein Screening, The Institute of Genetics and Cytology, School of Life Sciences, Northeast Normal University, Changchun 130024, People's Republic of China.
IUBMB Life. 2010 Sep;62(9):677-83. doi: 10.1002/iub.368.
It is well-known that vascular endothelial growth factor (VEGF) plays a key role in development and pathology, but its function in normal adult tissues is rarely understood. Increased use of anti-angiogenic therapies targeting VEGF in human pathologies have shown more and more adverse effects. In this report, a conditional expression model (Tet-On system) was used to down-regulate podocyte VEGF in adult mice, which resulted in many kidney problems, characterized by glomerular morphological changes, proteinuria, reduced water consumption and urination, increased urine electro-conductivity, as well as high susceptibility to BSA stress. Our findings indicated that podocyte-specific VEGF down-regulation resulted in poor kidney performance and led mice to be more susceptible to further kidney damages.
众所周知,血管内皮生长因子(VEGF)在发育和病理学中起着关键作用,但它在正常成年组织中的功能却鲜为人知。在人类病理学中越来越多地使用针对 VEGF 的抗血管生成疗法,显示出越来越多的不良反应。在本报告中,使用条件表达模型(Tet-On 系统)下调成年小鼠足细胞中的 VEGF,导致许多肾脏问题,表现为肾小球形态改变、蛋白尿、饮水和排尿减少、尿液电导率增加以及对 BSA 应激的高易感性。我们的研究结果表明,足细胞特异性 VEGF 下调导致肾脏功能不良,并使小鼠更容易受到进一步的肾脏损伤。